Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» OSE-230
OSE-230
AbbVie Puts Potential $713M on the Line for OSE’s Inflammation Antibody
BioSpace
Wed, 02/28/24 - 11:12 am
AbbVie
OSE Immunotherapeutics
OSE-230
inflammation
monoclonal antibodies